HK Stock Market Move | MINIEYE (02431) surged over 11%, uncrewed vehicle Little Bamboo T5 Pro recently won the first batch of orders.
YueXia Innovation (02431) rose by over 11% and, as of the time of writing, increased by 6.93% to HKD 8.64, with a trading volume of HKD 85.569 million.
MINIEYE (02431) surged by more than 11%, reaching a rise of 6.93% by the time of publication, closing at 8.64 Hong Kong dollars, with a trading volume of 85.569 million Hong Kong dollars.
On the news front, MINIEYE recently announced the signing of a "Unmanned Logistics Vehicle Procurement and Long-term Cooperation Agreement" with Jiangsu Danyang High-tech Industrial Development Co., Ltd., finalizing an order for 200 unmanned logistics vehicles. In this cooperation, MINIEYE will mass deliver the unmanned version of the Little Bamboo T5 Pro model, marking the first batch order obtained after the launch of the true unmanned vehicle, a significant milestone for the company's unmanned logistics vehicle business in commercialization and regional market expansion.
Currently, Little Bamboo unmanned logistics vehicles have been deployed in 18 cities including Guangzhou, Changsha, and Chongqing, covering a variety of scenarios such as express delivery, cold chain, and automotive parts, with a cooperation scale exceeding 7,000 vehicles. Caitong previously pointed out that the company's cockpit and driving synergy is significant, continuously gaining designated customers domestically and internationally; and with the mass production and delivery of L4 products, there is potential for new performance growth in the future.
Related Articles

Dohua Jixian: Raised BEKE-W (02423) target price to HK$53, upgraded to "Buy" rating

HK Stock Market Move | SKB BIO (06990) rose by over 5%, reaching the major endpoint of the global Phase III study of TROP2 ADC in collaboration with Merck.

HK Stock Market Move | ASCLETIS-B(01672) rose over 5% in early trading with GIC's shareholding ratio increasing to 7%. ASC30 US Phase II study has completed enrollment.
Dohua Jixian: Raised BEKE-W (02423) target price to HK$53, upgraded to "Buy" rating

HK Stock Market Move | SKB BIO (06990) rose by over 5%, reaching the major endpoint of the global Phase III study of TROP2 ADC in collaboration with Merck.

HK Stock Market Move | ASCLETIS-B(01672) rose over 5% in early trading with GIC's shareholding ratio increasing to 7%. ASC30 US Phase II study has completed enrollment.






